Industry Advisory Council

Home » Industry Advisory Council

Deborah Morosini, MD, MSW

VP, Clinical Affairs & Patient Engagement
Loxo Oncology, Inc.

Deborah Morosini

Dr. Deborah Morosini joined LOXO Oncology in 2016 as vice president of clinical affairs & patient engagement, bringing expertise in oncology drug development, clinical genomics and insightful philanthropic activism. Loxo Oncology, Inc. is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers. As an early team member & VP at Foundation Medicine (FMI), she developed a niche specialty in the genomics of adolescent and young adult (AYA) cancer. Prior to joining FMI, she founded and led the molecular pathology group at AstraZeneca US, where she helped develop and implement biomarker strategies for biomarker driven trials. She currently serves on the Board of Directors for the National Comprehensive Cancer Network (NCCN) Foundation, the Bonnie J. Addario Lung Cancer Foundation, the National Patient Advocate Foundation (NPAF) scientific advisory board, Target Cancer, the NHGRI council, Cancer Support Community: New Jersey, and the development subcommittee for the AYA cancer foundation, Critical Mass.

Pin It on Pinterest

Scroll to Top